Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function.

Autor: Bilbao-Meseguer I; Department of Pharmacy, Cruces University Hospital, Plaza de Cruces 12, 48903 Barakaldo, Spain.; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain., Barrasa H; Instituto de Investigación Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain.; Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain., Asín-Prieto E; Inserm U1070: Pharmacologie des Anti-Infectieux, Pôle Biologie Santé, Université de Poitiers, Bâtiment B36, 1 Rue Georges Bonnet, 86022 Poitiers, France., Alarcia-Lacalle A; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.; Instituto de Investigación Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain., Rodríguez-Gascón A; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.; Instituto de Investigación Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain., Maynar J; Instituto de Investigación Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain.; Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain., Sánchez-Izquierdo JÁ; Intensive Care Unit, Doce de Octubre Hospital, Avda de Córdoba, s/n, 28041 Madrid, Spain., Balziskueta G; Instituto de Investigación Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain.; Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain., Griffith MS; Intensive Care Unit, Doce de Octubre Hospital, Avda de Córdoba, s/n, 28041 Madrid, Spain., Quilez Trasobares N; Intensive Care Unit, Doce de Octubre Hospital, Avda de Córdoba, s/n, 28041 Madrid, Spain., Solinís MÁ; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.; Instituto de Investigación Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain., Isla A; Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.; Instituto de Investigación Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain.

Publikováno v: Pharmaceutics [Pharmaceutics] 2021 Oct 15; Vol. 13 (10). Date of Electronic Publication: 2021 Oct 15.

SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.

Autor: Barrasa H; Critical Care Department, Hospital Universitario de Alava, Spain., Rello J; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto Salud Carlos II, Madrid, Spain; Clinical Research in Pneumonia & Sepsis (CRIPS), Vall d'Hebron Institute of Research, Barcelona, Spain; Clinical Research, CHU Nîmes, University Montpellier - Nîmes, Nîmes, France., Tejada S; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto Salud Carlos II, Madrid, Spain; Clinical Research in Pneumonia & Sepsis (CRIPS), Vall d'Hebron Institute of Research, Barcelona, Spain. Electronic address: stmagraner@gmail.com., Martín A; Critical Care Department, Hospital Universitario de Alava, Spain., Balziskueta G; Critical Care Department, Hospital Universitario de Alava, Spain., Vinuesa C; Critical Care Department, Hospital Universitario de Alava, Spain., Fernández-Miret B; Critical Care Department, Hospital Universitario de Alava, Spain., Villagra A; Critical Care Department, Hospital Universitario de Alava, Spain., Vallejo A; Critical Care Department, Hospital Universitario de Alava, Spain., San Sebastián A; Critical Care Department, Hospital Universitario de Alava, Spain., Cabañes S; Critical Care Department, Hospital Universitario de Alava, Spain., Iribarren S; Critical Care Department, Hospital Universitario de Alava, Spain., Fonseca F; Critical Care Department, Hospital Universitario de Alava, Spain., Maynar J; Critical Care Department, Hospital Universitario de Alava, Spain.

Publikováno v: Anaesthesia, critical care & pain medicine [Anaesth Crit Care Pain Med] 2020 Oct; Vol. 39 (5), pp. 553-561. Date of Electronic Publication: 2020 Apr 09.

Lipid Accumulation in Host Cells Promotes SARS-CoV-2 Replication.

Autor: Seitz, Tatjana¹ (AUTHOR) tatjana.seitz@fau.de, Setz, Christian² (AUTHOR) christian.setz@uk-erlangen.de, Rauch, Pia² (AUTHOR), Schubert, Ulrich² (AUTHOR) ulrich.schubert@fau.de, Hellerbrand, Claus¹ (AUTHOR) ulrich.schubert@fau.de

Publikováno v: Viruses (1999-4915). Apr2023, Vol. 15 Issue 4, p1026. 7p.

Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis.

Autor: Uruma, Yuka¹ (AUTHOR), Manabe, Toshie^2,3 (AUTHOR) crmanabe@med.nagoya-cu.ac.jp, Fujikura, Yuji^4,5 (AUTHOR), Iikura, Motoyasu⁶ (AUTHOR), Hojo, Masayuki⁶ (AUTHOR), Kudo, Koichiro^7,8 (AUTHOR)

Publikováno v: PLoS ONE. 11/1/2022, Vol. 17 Issue 11, p1-26. 26p.

Correlation between Type I Interferon Associated Factors and COVID-19 Severity.

Autor: Bencze, Dóra^1,2 (AUTHOR), Fekete, Tünde¹ (AUTHOR), Pázmándi, Kitti¹ (AUTHOR) pazmandi.kitti@med.unideb.hu

Publikováno v: International Journal of Molecular Sciences. Sep2022, Vol. 23 Issue 18, pN.PAG-N.PAG. 26p.